Clinical Trial Update: Body Composition Sub-study of the D2EFT Trial [Phase 4]

View source ↗

Summary

This document reports the completion status of a body composition sub-study within the D2EFT Phase 4 trial for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: Kirby Institute | Conditions: HIV Infections | Phase 4 | Status: COMPLETED